Serum level of adiponectin as a risk marker for cardiovascular and type 2 diabetes mellitus patients

Abstract EN

Adiponectin has anti-atherogenic and anti-inflammatory properties.

its' study as a risk marker for Cardiovascular and type -2- diabetes mellitus patients.

This study was done in the period from 1 / 7 / 2011 to 1 / 11 / 2012 in Al-Hussein hospital in Karballa government.

The study groups were divided into four groups, one is control, the others were patients (type -2- diabetic, type - 2- diabetic with cardiovascular and Cardiovascular diseases).

The results were showed, there were lowering in fasting serum adiponectin hormone concentration for (three study groups) with respect to than normal subjects, significant different (p < 0.001) When use adiponectin measurement as a marker to limitation the kind of pathogenic case and from Least Significant different (L..S.D) a statistical system were observed there were highly significant different between DMII group compared to control group while there were medium significant different with (DMII- CVD and CVD) groups.

The results indicated that there were no significant different between (DMII-CVD and CVD) groups.

While there were a significant difference between(DMII-CVD and CVD) groups and control group less than previous group DMII.

Therefore concentration of adiponectin was considered as predictor of incident of diabetes mellitus more than cardiovascular diseases.